#:# randomization

Related by string. * #:# [014] . #:# [017] . #:# [016] . #:# [004] . #:# [003] . #:# [005] . #:# - : #-#:# pm [001] . TEAM #:# MISSED . #:# AM ET [002] . #.#.# #:# AM EDT . #.#.# #:# PM EDT . #.#.# #:# AM ET . #:# AM ET [001] / Randomization : space layout randomization . Space Layout Randomization . Mendelian randomization . Layout Randomization . #:#:# randomization . randomization * *

Related by context. Frequent words. (Click for all words.) 69 active comparator 63 double blinded placebo 62 multicenter randomized double 62 mg QD 62 glatiramer acetate 62 blinded placebo controlled 61 FOLFOX 61 XELOX 61 tanespimycin 61 Pivotal Phase 61 mg BID 61 Amrubicin 61 Phase 1a 61 relapsed refractory multiple myeloma 61 randomized #:# 60 Pioglitazone 60 placebo controlled clinical 60 plus prednisone 60 Pivotal Phase III 60 #mg dose [003] 60 randomized 60 tipranavir 59 Gemcitabine 59 nab paclitaxel 59 peginterferon alfa 2b 59 phase IIb 59 prospective randomized controlled 59 Irinotecan 59 Lenalidomide 59 Taxotere ® 59 abciximab 59 FOLFIRI 59 Erlotinib 58 adalimumab 58 #mg/kg [002] 58 SCH # 58 Phase 1b clinical 58 phase IIa 58 6R BH4 58 serum phosphorus 58 dabigatran etexilate 58 unfractionated heparin 58 achieved statistical significance 58 mcg kg 58 randomisation 58 composite endpoint 58 dacarbazine 58 plus gemcitabine 58 dose regimens 58 administered subcutaneously 57 Randomized 57 PA# [002] 57 FOSRENOL R 57 #mg dose [001] 57 rHuPH# 57 CRx 57 dose cohorts 57 valsartan 57 placebo controlled randomized 57 Phase III randomized 57 vicriviroc 57 blind randomized 57 fondaparinux 57 Pivotal Trial 57 NOXAFIL 57 neoadjuvant 57 dose escalation 57 Secondary endpoints 57 placebo controlled studies 57 tiotropium 57 thymalfasin 56 decitabine 56 metastatic renal cell carcinoma 56 randomized double 56 Torisel 56 Phase 2b study 56 glimepiride 56 multicenter randomized 56 intravenously administered 56 Tolerability 56 placebo controlled trials 56 Navelbine 56 peginterferon alfa 2a 56 vinorelbine 56 secondary efficacy endpoints 56 mg kg dose 56 TORISEL 56 multicentre 56 label multicenter 56 dose escalation trial 56 randomized controlled 56 sitagliptin 56 Monotherapy 56 fluorouracil 56 fluticasone propionate 56 pazopanib 56 esomeprazole 56 prospective observational 56 warfarin therapy 56 PROMACTA 56 Combination therapy

Back to home page